Pharma giant Roche Holding AG (RHHBY.PK) said it has increased its offer price for all outstanding publicly-held shares of Illumina, Inc. (ILMN) to $51 per share in cash. All other terms and conditions of the tender offer remain unchanged, the company added.
Severin Schwan, chief executive officer of Roche, stated, "Based on our discussions with Illumina shareholders we have seen interest to accelerate the takeover process. As a result, we are increasing our offer price to US$ 51.00 per share. Roche's preference continues to be a negotiated transaction. We look forward to the possibility of a swift completion that offers immediate value to Illumina's shareholders."
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org